Bulk Manufacturer of Controlled Substances Application: Patheon Pharmaceuticals, Inc., 15571 [2016-06539]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 56 / Wednesday, March 23, 2016 / Notices
Dated: March 14, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
DEPARTMENT OF LABOR
[FR Doc. 2016–06548 Filed 3–22–16; 8:45 am]
Occupational Safety and Health
Administration
BILLING CODE 4410–09–P
[Docket No. OSHA–2016–0008]
DEPARTMENT OF JUSTICE
Whistleblower Protection Advisory
Committee (WPAC)
Drug Enforcement Administration
AGENCY:
Occupational Safety and Health
Administration (OSHA), Labor.
ACTION: Announcement of a meeting of
WPAC.
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Patheon
Pharmaceuticals, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic class, and applicants
therefore, may file written comments on
or objections to the issuance of the
proposed registration in accordance
with 21 CFR 1301.33(a) on or before
May 23, 2016.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on
December 10, 2015, Patheon
Pharmaceuticals, Inc., 2110 E. Galbraith
Road, Cincinnati, Ohio 45237 applied to
be registered as a bulk manufacturer of
gamma hydroxybutyric acid (2010) a
basic class of controlled substance listed
in schedule I.
The company plans to manufacture
the listed controlled substance for
product development.
jstallworth on DSK7TPTVN1PROD with NOTICES
DATES:
Dated: March 14, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016–06539 Filed 3–22–16; 8:45 am]
BILLING CODE 4410–09–P
VerDate Sep<11>2014
15:26 Mar 22, 2016
Jkt 238001
WPAC will meet April 26,
2016, in Washington, DC.
DATES: WPAC meeting: WPAC will meet
from 9:00 a.m. to 4:00 p.m., E.T.,
Tuesday, April 26, 2015.
Written comments, requests to speak,
speaker presentations, and requests for
special accommodation: You must
submit (postmark, send, transmit)
comments, requests to address the
WPAC meeting, speaker presentations
(written or electronic), and requests for
special accommodations for the WPAC
meeting by April 12, 2016.
ADDRESSES: WPAC meeting: WPAC will
meet in Room N–4437 A–C, U.S.
Department of Labor, Francis Perkins
Building, 200 Constitution Avenue NW.,
Washington, DC 20210.
Submission of comments, requests to
speak, and speaker presentations: You
may submit comments, requests to
speak at the WPAC meeting, and
speaker presentations using one of the
following methods:
Electronically: You may submit
materials, including attachments,
electronically at https://
www.regulations.gov, which is the
Federal eRulemaking Portal. Follow the
on-line instructions for submissions.
Facsimile (Fax): If your submission,
including attachments, does not exceed
10 pages, you may fax it to the OSHA
Docket Office at (202) 693–1648.
Regular mail, express mail, hand
delivery, or messenger (courier) service:
You may submit your materials to the
OSHA Docket Office, Docket No.
OSHA–2016–0008, Room N–2625, U.S.
Department of Labor, 200 Constitution
Avenue NW., Washington, DC 20210;
telephone (202) 693–2350 (TTY (877)
889–5627). OSHA’s Docket Office
accepts deliveries (hand deliveries,
express mail, and messenger service)
during normal business hours, 8:15
a.m.–4:45 p.m., E.T., weekdays.
Requests for special accommodations:
Please submit any requests for special
accommodations to attend the WPAC
meeting to Ms. Gretta Jameson, OSHA,
Office of Communications, Room N–
3647, U.S. Department of Labor, 200
SUMMARY:
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
15571
Constitution Avenue NW., Washington,
DC 20210; telephone (202) 693–1999;
email jameson.grettah@dol.gov.
Instructions: Your submissions must
include the agency name and docket
number for this Federal Register notice
(Docket No. OSHA–2016–0008). Due to
security-related procedures,
submissions by regular mail may
experience significant delays. Please
contact the OSHA Docket Office for
information about security procedures
for making submissions. For additional
information on submitting comments,
requests to speak, and speaker
presentations, see the SUPPLEMENTARY
INFORMATION section of this notice.
FOR FURTHER INFORMATION CONTACT:
For press inquiries: Mr. Frank
Meilinger, Director, OSHA Office of
Communications, Room N–3647, U.S.
Department of Labor, 200 Constitution
Avenue NW., Washington, DC 20210;
telephone (202) 693–1999; email
meilinger.francis2@dol.gov.
For general information about WPAC
and WPAC meetings: Mr. Anthony Rosa,
OSHA, Directorate of Whistleblower
Protection Programs, Room N–4618,
U.S. Department of Labor, 200
Constitution Avenue NW., Washington,
DC 20210; telephone (202) 693–2199;
email osha.dwpp@dol.gov.
SUPPLEMENTARY INFORMATION:
WPAC Meeting
WPAC will meet Tuesday, April 26,
2015, in Washington, DC. WPAC
meetings are open to the public.
The tentative agenda of the WPAC
meeting includes:
Remarks from the Assistant Secretary of
Labor for Occupational Safety and Health
(OSHA);
Remarks from the Director of the Directorate
of Whistleblower Protection Programs;
Presentations from other federal agencies
with whistleblower programs;
Railroad worker whistleblower presentation;
Public comments;
Work Group presentations; and,
Old business.
OSHA transcribes WPAC meetings and
prepares detailed minutes of the
meetings. OSHA places the meeting
transcripts and minutes in the public
record of the WPAC meeting. The public
record also includes Work Group
reports, speaker presentations,
comments and other materials
submitted to WPAC.
WPAC Work Groups
The WPAC work groups (Outreach
and Training) will meet on April 25,
2016. These work group meetings will
be open to the public. The purpose of
the work groups is to provide
recommendations to the full WPAC
E:\FR\FM\23MRN1.SGM
23MRN1
]]>Agencies
[Federal Register Volume 81, Number 56 (Wednesday, March 23, 2016)]
[Notices]
[Page 15571]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-06539]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Patheon
Pharmaceuticals, Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic class, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.33(a) on or before May 23, 2016.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/ODW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated her
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Deputy Assistant Administrator of the DEA Office of Diversion
Control (``Deputy Assistant Administrator'') pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on
December 10, 2015, Patheon Pharmaceuticals, Inc., 2110 E. Galbraith
Road, Cincinnati, Ohio 45237 applied to be registered as a bulk
manufacturer of gamma hydroxybutyric acid (2010) a basic class of
controlled substance listed in schedule I.
The company plans to manufacture the listed controlled substance
for product development.
Dated: March 14, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-06539 Filed 3-22-16; 8:45 am]
BILLING CODE 4410-09-P
